Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 805, pseudogene (RNU6-805P)
- Target
- RNU6-805P
- Molecular classification
- Small nuclear RNA (snRNA), Non-coding RNA, Pseudogene, Other (not a protein-coding gene or classic receptor/target)
01
Overview
RNU6-805P represents a pseudogene copy of the U6 small nuclear RNA gene, specifically annotated as "U6 small nuclear 805." The gene product is a pseudogene derived from snRNA involved in pre-mRNA splicing, but as a pseudogene, it does not produce a functional RNA or protein. U6 snRNA itself is an essential component of the spliceosome, which catalyzes intron removal from pre-mRNA, but pseudogenes like RNU6-805P are considered non-functional genomic elements that have arisen through retrotransposition events, often mediated by LINE-1 activity[2][4][5]. RNU6-805P is highly conserved as part of the family of U6 snRNA gene copies and pseudogenes abundant in vertebrate genomes, but unlike the canonical U6 gene, it does not encode a functional product and is not involved in splicing or known disease processes[5]. It is not a drug target, does not interact with drugs, and is not used as a biomarker or associated with safety concerns[2][5].
- Other names
- RNU6-805PU6 snRNA pseudogene 805RNA, U6 Small Nuclear 805, Pseudogene
02
Biological functions
Other (does not have a direct biological function; is a processed pseudogene)
03
Disease associations
Other (no established disease role; not implicated as a causative or contributing factor)
Beyond the preview
Go deeper on RNA, U6 small nuclear 805, pseudogene (RNU6-805P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 805, pseudogene (RNU6-805P).